Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)
Amgen announced on the 27th August, 2018 the submission of a supplemental New Drug Application (sNDA) to the U.S. Food
A forum for researchers, students and applicants in the field of cyclodextrin technology
Amgen announced on the 27th August, 2018 the submission of a supplemental New Drug Application (sNDA) to the U.S. Food
Cyclodextrin-containing polymer (CDP) (represented by blue in the scheme) conjugated to camptothecin (CPT) (represented by red) forms 30-40-nm diameter nanoparticles
Several cyclodextrins have been claimed by dozens of papers including huge works of Serno [1] and Hartl [2] to be
Prof. Thorsteinn Loftsson (University of Iceland) explains in his lecture on the website of CyclonHit project the mechanism how drugs
The video of Prof. Thorsteinn Loftsson on the website of CyclonHit project gives the basic information on the effect of
The video of Prof. Thorsteinn Loftsson shows how to perform solubility studies, the types of phase-solubility isotherms, continuous variation plots
The video of Prof. Thorsteinn Loftsson on the website of CycloHit project gives a summary on the physicochemical and pharmacokinetic
The biggest pharma exhibition in the world, CPHI Worldwide will be organized 9-11th October in Madrid. By joining (which is
For those, interested in building relationships with industrial partners as well as broadening their knowledge in state-of-the-art academic research, AAPS
The application of cyclodextrins as excipients is wellspread, common knowledge worldwide. Their application as APIs is getting huge publicity, developments